Optical coherence tomography angiography in healthy subjects and patients with retinal vascular diseases.
Recruiting
- Conditions
- Retinal vascular diseases
- Registration Number
- ACTRN12617001633370
- Lead Sponsor
- lions eye institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways correlate with OCTA parameter changes in retinal vascular diseases like AMD and DR?
How does OCTA angiography compare to fluorescein angiography in detecting neovascularization in diabetic retinopathy?
Which OCTA-derived biomarkers predict treatment response in retinal vein occlusion and age-related macular degeneration?
What adverse events are associated with OCTA imaging in retinal vascular disease patients, and how are they managed?
How do OCTA parameters inform anti-VEGF therapy optimization in neovascular AMD and diabetic macular edema?